“When we acquired Diapath, our vision was clear: to expand access to the most innovative histology instrumentation worldwide,” StatLab CEO Dae Hong said.
McKinney-based StatLab said the moves mark "a significant step forward" in its European growth strategy, expanding its direct commercial presence to the top four European markets: France, Germany, Italy, and the U.K.
McKinney-based StatLab Medical Products is scaling its global reach with a series of strategic moves, including acquisitions and expanded facilities, such as a new one in Arlington. CEO Sung-Dae Hong, who took the helm this time last year, brings decades of experience in driving growth and M&A.
StatLab said its 2022 acquisition of Wales-based CellPath Ltd.—known for injection molding manufacturing of histology supplies—served as a catalyst for its new, 35,000-square-foot facility in Arlington.
Nonprofit startup accelerator MassChallenge established its second U.S. headquarters in Dallas, thanks to continued financial support from Dallas’ Lyda Hill Philanthropies.
Boston-based MassChallenge came to North Texas in 2022 with money from Lyda Hill Philanthropies....
Nonprofit startup accelerator MassChallenge established its second U.S. headquarters in Dallas, thanks to continued financial support from Dallas’ Lyda Hill Philanthropies.
Boston-based MassChallenge came to North Texas in 2022 with money from Lyda Hill Philanthropies....